We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
United Microelectronic
UMC
$48.9B
| $8.73K | ﹤0.01% |
321
+3
| +0.9% | +$51 |
|
2277
McCormick & Company Non-Voting
MKC
$13.4B
| $8.72K | ﹤0.01% |
173
-123
| -42% | -$6.04K |
|
2278
Chunghwa Telecom
CHT
$33.2B
| $8.72K | ﹤0.01% |
197
+35
| +22% | +$1.54K |
|
|
LIF
2279
Life360
LIF
$3.96B
| $8.69K | ﹤0.01% |
157
-18
| -10% | -$800 |
|
2280
Lucid Motors
LCID
$2.46B
| $8.6K | ﹤0.01% |
1,286
+846
| +192% | +$5.46K |
|
2281
F&G Annuities & Life
FG
$3.93B
| $8.59K | ﹤0.01% |
323
| – | – |
|
2282
Woori Financial
WF
$15.8B
| $8.55K | ﹤0.01% |
149
+71
| +91% | +$4.61K |
|
|
BLSH
2283
Bullish
BLSH
$3.63B
| $8.53K | ﹤0.01% |
364
+343
| +1,633% | +$11.9K |
|
2284
Phreesia
PHR
$632M
| $8.47K | ﹤0.01% |
823
-883
| -52% | -$8.2K |
|
|
GLIBA
2285
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$891M
| $8.43K | ﹤0.01% |
385
+277
| +256% | +$7.83K |
|
2286
Mission Produce
AVO
$1.1B
| $8.43K | ﹤0.01% |
715
+71
| +11% | +$897 |
|
2287
Theravance Biopharma
TBPH
$874M
| $8.38K | ﹤0.01% |
493
+68
| +16% | +$1.13K |
|
2288
Genius Sports
GENI
$1.73B
| $8.38K | ﹤0.01% |
1,382
-572
| -29% | -$2.96K |
|
2289
ICICI Bank
IBN
$106B
| $8.24K | ﹤0.01% |
284
+116
| +69% | +$3.14K |
|
2290
Mirum Pharmaceuticals
MIRM
$6.89B
| $8.2K | ﹤0.01% |
70
+12
| +21% | +$1.21K |
|
2291
OneWater Marine
ONEW
$214M
| $8.17K | ﹤0.01% |
725
-224
| -24% | -$2.41K |
|
|
PDM
2292
Piedmont Realty Trust
PDM
$1.22B
| $8.14K | ﹤0.01% |
890
+138
| +18% | +$1.14K |
|
2293
Sarepta Therapeutics
SRPT
$1.66B
| $8.09K | ﹤0.01% |
450
-196
| -30% | -$3.71K |
|
2294
Molson Coors Class B
TAP
$7.68B
| $8.06K | ﹤0.01% |
207
-1,930
| -90% | -$80.6K |
|
2295
Trump Media & Technology Group
DJT
$2.37B
| $8.06K | ﹤0.01% |
1,042
+269
| +35% | +$2.37K |
|
2296
Choice Hotels
CHH
$5.03B
| $8.05K | ﹤0.01% |
73
+15
| +26% | +$1.66K |
|
2297
NBT Bancorp
NBTB
$2.72B
| $8.05K | ﹤0.01% |
163
| – | – |
|
2298
Cooper-Standard Automotive
CPS
$504M
| $8.01K | ﹤0.01% |
296
| – | – |
|
2299
Excelerate Energy
EE
$1.23B
| $7.98K | ﹤0.01% |
210
| – | – |
|
|
TPC
2300
Tutor Perini Cor
TPC
$4.57B
| $7.96K | ﹤0.01% |
96
+9
| +10% | +$724 |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.